Last updated on November 2008

Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study


Brief description of study

The purpose of the Study is to determine whether early treatment with pravastatin can reduce adverse cardiac events in patients with acute myocardial infarction and minimally to mildly elevated serum Low Density Lipoprotein -Cholesterol (LDL-C) levels.

Detailed Study Description

The investigators previously reported the beneficial effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction and mild to moderate hypercholesterolemia in the OACIS-LIPID Study. The PRACTIC study is designed as the OACIS-LIPID II trial to determine whether early treatment with pravastatin can reduce adverse cardiac events in patients with acute myocardial infarction and minimally to mildly elevated serum Low Density Lipoprotein -Cholesterol (LDL-C) levels.

Clinical Study Identifier: NCT00688922

Contact Investigators or Research Sites near you

Start Over

Yasuhiko Sakata, MD/PhD

Osaka University Hospital
Suita, Japan
4.09miles
  Connect »

Shinnsuke Nanto, MD/PhD

Kansai Rosai Hospital
Amagasaki, Japan
4.87miles
  Connect »

Masatake Fukunami, MD/PhD

Osaka General Medical Center
Osaka, Japan
6.32miles
  Connect »

Yasunori Ueda, MD/PhD

Osaka Police Hospital
Osaka, Japan
6.32miles
  Connect »

Hiroshi Ito, MD/PhD

Sakurabashi Watanabe Hospital
Osaka, Japan
6.32miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.